Add BrightSurf on Google Email

Researchers unravel a novel mechanism regulating gene expression in the brain that could guide solutions to circadian and other disorders

Researchers have identified a novel mechanism controlling circadian gene expression and behavioral rhythms through chemical bonding of monoamine neurotransmitters to histone proteins. This discovery could lead to targeted therapies for conditions involving circadian rhythm disruptions, such as insomnia and depression.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature·TypeExperimental study·DateJan 8, 2025

New study reveals unique histone tag in adult oligodendrocyte progenitor cells, opening doors for advanced myelin repair therapies

Researchers at CUNY ASRC identify distinct histone tag in adult oligodendrocyte progenitor cells that regulates their proliferation and may lead to innovative therapies for neurodegenerative diseases. The discovery holds promise for advancing myelin repair and improving patient outcomes.

SourceAdvanced Science Research Center, GC/CUNY·JournalJournal of Cell Biology·TypeExperimental study·DateAug 12, 2024

MMRI publishes breakthrough study detailing a novel approach to minimize damage after a heart attack

Researchers at MMRI have developed a novel approach to minimize cardiac damage after a heart attack by targeting the spleen with histone deacetylase inhibitors. This targeting strategy results in a significant decrease in cardiac scar size and preservation of heart function, even after just one dose.

SourceMasonic Medical Research Institute·JournalAdvanced Materials·TypeExperimental study·DateDec 20, 2023

How plants pass down genetic memories

Researchers have discovered how plants pass along chemical markers that instruct cells on using DNA codes, a process known as epigenetic inheritance. The study reveals the role of protein DDM1 in making way for enzymes that add regulatory marks to new DNA strands, preserving genetic controls across generations.

A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

A new multiplex assay has been developed to assess activated p300/CBP in circulating prostate tumor cells, revealing correlations with clinical outcomes and potential therapeutic targets for castration-resistant prostate cancer. The study found that patients with upregulated p300/CBP activity had shorter response times to ARSI therapy.

SourceImpact Journals LLC·JournalOncotarget·TypeExperimental study·DateJul 24, 2023

New insights into centromere structure

Researchers at Osaka University used cryogenic electron microscopy to study the structural change of the centromere during cell division. The study revealed a complex interaction between proteins involved in cell division, providing new insights into the correct division of chromosomes.

SourceOsaka University·JournalThe EMBO Journal·TypeExperimental study·DateFeb 6, 2023

Radiation damage to paternal DNA is passed on to offspring

Researchers discovered that radiation damage to paternal DNA is passed on to offspring through a highly error-prone repair mechanism. This leads to structural changes in the paternal chromosomes and causes developmental defects. Histone proteins play a crucial role in shielding damaged chromosomes from accurate repair.

SourceUniversity of Cologne·JournalNature·TypeObservational study·DateDec 21, 2022

Unraveling the biology behind aggressive pediatric brain tumor reveals potential new treatment avenue

Researchers developed a mouse model of pediatric glioma with a histone mutation called H3.3-G34, revealing a promising outlook for long-term survival through radiation therapy combined with small-molecule inhibitors. The treatment approach also showed immune memory, allowing mice to eliminate new tumor growth without additional treatment.

SourceMichigan Medicine - University of Michigan·JournalJournal of Clinical Investigation·TypeExperimental study·DateNov 15, 2022

An epigenetic cause of miscarriages is identified and cured in mice

Researchers have identified the Xist gene as a critical regulator of fetal development in mice, leading to miscarriage and abnormal placentas when epigenetic instructions are missing. The study's findings suggest that failed Xist imprinting can be 'cured' by targeting specific genes involved in histone modifications.

SourceRIKEN·JournalGenes & Development·DateApr 27, 2022